arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Anixa Biosciences Inc

ANIX

$3.02 ▼ -0.25 (-7.63%) at close

16 Visible periods

24 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Anixa Biosciences Inc faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC -61.0% ↘

FCF / Share —

Trailing P/E —

Price / Book 6.6x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

16-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$210.00K

— 0.0% —

Net Income Profit after all expenses

$-10.93M

↑ +13.0% —

Operating Margin Operating profit as % of sales

-10.2%

↑ +92.6% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2025 Oct 31, 2025 10-K ↗	FY 2024 Oct 31, 2024 10-K ↗	FY 2023 Oct 31, 2023 10-K ↗	FY 2022 Oct 31, 2022 10-K ↗	FY 2021 Oct 31, 2021 10-K ↗	FY 2020 Oct 31, 2020 10-K ↗	FY 2019 Oct 31, 2019 10-K ↗	FY 2018 Oct 31, 2018 10-K ↗	FY 2017 Oct 31, 2017 10-K ↗	FY 2016 Oct 31, 2016 10-K ↗	FY 2015 Oct 31, 2015 10-K ↗	FY 2014 Oct 31, 2014 10-K ↗	FY 2013 Oct 31, 2012 10-K ↗	FY 2012 Oct 31, 2011 10-K ↗	FY 2011 Oct 31, 2010 10-K ↗	FY 2010 Oct 31, 2009 10-K ↗
Revenue Growth YoY (%)	—	0.0% Caution Caution Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	—	—	—	—	-77.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1069%)	206.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2486%)	20.8% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+160%)	-96.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1309%)	152.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1805%)	287.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3490%)	-5.6% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-170%)	37.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+366%)	—	—
EPS Growth YoY (%)	12.8% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	N/M	-28.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	13.0% Fair ↑ Fair Improving Year-over-year change in net income	-28.0% Weak ↓ Weak Declining Year-over-year change in net income	27.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-4.9% Weak ↓ Weak Declining Year-over-year change in net income	-29.3% Weak ↑ Weak Improving Year-over-year change in net income	14.0% Fair ↑ Fair Improving Year-over-year change in net income	16.8% Good ↑ Good Improving Year-over-year change in net income	-179.4% Weak ↓ Weak Declining Year-over-year change in net income	0.1% Caution ↑ Caution Improving Year-over-year change in net income	-263.8% Weak ↓ Weak Declining Year-over-year change in net income	85.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-125.9% Weak ↓ Weak Declining Year-over-year change in net income	42.4% Excellent Excellent Year-over-year change in net income	-42.6% Weak Weak Year-over-year change in net income	—	—
Revenue CAGR 3Y (%)	—	-25.7% Weak Weak Compound annual revenue growth over 3 years	—	—	-22.8% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	—	-5.9% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-50.6% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-53.8% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-31.8% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	109.7% Excellent Excellent Compound annual revenue growth over 3 years	71.2% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	—	-3.4% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	-28.4% Weak Weak Compound annual revenue growth over 5 years	—	11.3% Good ↑ Good Improving Compound annual revenue growth over 5 years	—	-41.6% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	3.3% Caution ↑ Caution Improving Compound annual revenue growth over 5 years	-18.4% Weak Weak Compound annual revenue growth over 5 years	-16.3% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Oct 31, 2025 10-K ↗	FY 2024 Oct 31, 2024 10-K ↗	FY 2023 Oct 31, 2023 10-K ↗	FY 2022 Oct 31, 2022 10-K ↗	FY 2021 Oct 31, 2021 10-K ↗	FY 2020 Oct 31, 2020 10-K ↗	FY 2019 Oct 31, 2019 10-K ↗	FY 2018 Oct 31, 2018 10-K ↗	FY 2017 Oct 31, 2017 10-K ↗	FY 2016 Oct 31, 2016 10-K ↗	FY 2015 Oct 31, 2015 10-K ↗	FY 2014 Oct 31, 2014 10-K ↗	FY 2013 Oct 31, 2012 10-K ↗	FY 2012 Oct 31, 2011 10-K ↗	FY 2011 Oct 31, 2010 10-K ↗	FY 2010 Oct 31, 2009 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	-10.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-168%)	-137.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1017%)	-436.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3010%)	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	-14.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-224%)	-261.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2283%)	-449.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3842%)	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	-387.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	14.1% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	-65.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-331.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-72.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-329.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.66x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.58x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.63x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.48x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	0.38x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.62x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.42x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.31x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.70x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-0.95x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.25x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.10x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.47x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Oct 31, 2025 10-K ↗	FY 2024 Oct 31, 2024 10-K ↗	FY 2023 Oct 31, 2023 10-K ↗	FY 2022 Oct 31, 2022 10-K ↗	FY 2021 Oct 31, 2021 10-K ↗	FY 2020 Oct 31, 2020 10-K ↗	FY 2019 Oct 31, 2019 10-K ↗	FY 2018 Oct 31, 2018 10-K ↗	FY 2017 Oct 31, 2017 10-K ↗	FY 2016 Oct 31, 2016 10-K ↗	FY 2015 Oct 31, 2015 10-K ↗	FY 2014 Oct 31, 2014 10-K ↗	FY 2013 Oct 31, 2012 10-K ↗	FY 2012 Oct 31, 2011 10-K ↗	FY 2011 Oct 31, 2010 10-K ↗	FY 2010 Oct 31, 2009 10-K ↗
Return on Invested Capital (%)	-61.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-54.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-35.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-37.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-29.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-90.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-179.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-207.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-60.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-360.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	120.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	273.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-375.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-90.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-72.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-64.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-43.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-45.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-36.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-105.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-188.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-221.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-68.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-80.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-55.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-73.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-58.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-52.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-72.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-580%)	-62.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-519%)	-40.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-369%)	-46.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-412%)	-36.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-344%)	-114.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-862%)	-222.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1583%)	-257.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1817%)	-63.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-521%)	—	-27.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-282%)	289.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1829%)	—	—	-112.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-851%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Oct 31, 2025 10-K ↗	FY 2024 Oct 31, 2024 10-K ↗	FY 2023 Oct 31, 2023 10-K ↗	FY 2022 Oct 31, 2022 10-K ↗	FY 2021 Oct 31, 2021 10-K ↗	FY 2020 Oct 31, 2020 10-K ↗	FY 2019 Oct 31, 2019 10-K ↗	FY 2018 Oct 31, 2018 10-K ↗	FY 2017 Oct 31, 2017 10-K ↗	FY 2016 Oct 31, 2016 10-K ↗	FY 2015 Oct 31, 2015 10-K ↗	FY 2014 Oct 31, 2014 10-K ↗	FY 2013 Oct 31, 2012 10-K ↗	FY 2012 Oct 31, 2011 10-K ↗	FY 2011 Oct 31, 2010 10-K ↗	FY 2010 Oct 31, 2009 10-K ↗
Interest Coverage (x)	—	—	—	—	-6568.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-250.14x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-213.35x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-12.14x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-8.67x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2.09x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3.99x Weak Weak Operating income divided by interest expense Optimal: > 5x	-539.48x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$-1.24M	$-1.27M	$-915.00K	$-12.36M	$-29.13M	$-6.42M	$-3.49M	$-3.06M	$-3.34M	$-2.49M	$-4.37M	$-898.17K	$-339.69K	$-774.04K	$-1.09M	$-1.45M

📊 What does each share earn? 4 metrics

Metric	FY 2025 Oct 31, 2025 10-K ↗	FY 2024 Oct 31, 2024 10-K ↗	FY 2023 Oct 31, 2023 10-K ↗	FY 2022 Oct 31, 2022 10-K ↗	FY 2021 Oct 31, 2021 10-K ↗	FY 2020 Oct 31, 2020 10-K ↗	FY 2019 Oct 31, 2019 10-K ↗	FY 2018 Oct 31, 2018 10-K ↗	FY 2017 Oct 31, 2017 10-K ↗	FY 2016 Oct 31, 2016 10-K ↗	FY 2015 Oct 31, 2015 10-K ↗	FY 2014 Oct 31, 2014 10-K ↗	FY 2013 Oct 31, 2012 10-K ↗	FY 2012 Oct 31, 2011 10-K ↗	FY 2011 Oct 31, 2010 10-K ↗	FY 2010 Oct 31, 2009 10-K ↗
Basic EPS, GAAP (USD)	$-0.34	$-0.39	$0.32	$0.45	$-0.45	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.46	$0.62	$0.78	$0.94	$1.18	$0.36	$0.26	$0.29	$0.48	$0.11	$0.58	$-0.38	$-0.01	$0.01	$0.03	—
Tangible Book Value per Share (USD)	$0.46	$0.62	$0.78	$0.94	$1.18	$0.36	$0.26	$0.29	$0.48	$0.11	$0.58	$-0.38	$-0.01	$0.01	$0.03	—
Basic Weighted Avg Shares (shares)	32,454	31,898	30,980	30,374	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Oct 31, 2025 10-K ↗	FY 2024 Oct 31, 2024 10-K ↗	FY 2023 Oct 31, 2023 10-K ↗	FY 2022 Oct 31, 2022 10-K ↗	FY 2021 Oct 31, 2021 10-K ↗	FY 2020 Oct 31, 2020 10-K ↗	FY 2019 Oct 31, 2019 10-K ↗	FY 2018 Oct 31, 2018 10-K ↗	FY 2017 Oct 31, 2017 10-K ↗	FY 2016 Oct 31, 2016 10-K ↗	FY 2015 Oct 31, 2015 10-K ↗	FY 2014 Oct 31, 2014 10-K ↗	FY 2013 Oct 31, 2012 10-K ↗	FY 2012 Oct 31, 2011 10-K ↗	FY 2011 Oct 31, 2010 10-K ↗	FY 2010 Oct 31, 2009 10-K ↗
Working Capital (USD)	$13.92M	$18.86M	$23.33M	$28.16M	$34.73M	$8.18M	$4.61M	$4.27M	$6.12M	$2.93M	$6.30M	$4.51M	$-900.44K	$1.02M	$784.77K	—
Total Equity (USD)	$15.16M	$20.00M	$24.34M	$29.05M	$35.44M	$8.76M	$5.24M	$5.43M	$7.92M	$987.48K	$5.05M	$-3.32M	$-1.19M	$1.06M	$4.60M	$4.45M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Oct 31, 2025 10-K ↗	FY 2024 Oct 31, 2024 10-K ↗	FY 2023 Oct 31, 2023 10-K ↗	FY 2022 Oct 31, 2022 10-K ↗	FY 2021 Oct 31, 2021 10-K ↗	FY 2020 Oct 31, 2020 10-K ↗	FY 2019 Oct 31, 2019 10-K ↗	FY 2018 Oct 31, 2018 10-K ↗	FY 2017 Oct 31, 2017 10-K ↗	FY 2016 Oct 31, 2016 10-K ↗	FY 2015 Oct 31, 2015 10-K ↗	FY 2014 Oct 31, 2014 10-K ↗	FY 2013 Oct 31, 2012 10-K ↗	FY 2012 Oct 31, 2011 10-K ↗	FY 2011 Oct 31, 2010 10-K ↗	FY 2010 Oct 31, 2009 10-K ↗
Sales/Revenue/Turnover (USD)	—	$210.00K	$210.00K	—	$512.00K	—	$250.00K	$1.11M	$362.50K	$300.00K	$9.26M	$3.67M	$947.09K	$1.00M	$730.67K	—
Depreciation Expense (USD)	—	—	—	—	—	$38.28K	$47.56K	—	—	—	—	—	—	—	$8.36K	—
Net Income, GAAP (USD)	$-10.93M	$-12.55M	$-9.81M	$-13.60M	$-12.95M	$-10.02M	$-11.65M	$-14.00M	$-5.01M	$-5.02M	$-1.38M	$-9.61M	$-4.25M	$-7.38M	$-5.18M	—
Operating Cash Flow (USD)	$-7.17M	$-7.33M	$-6.21M	$-6.49M	$-4.94M	$-6.18M	$-4.74M	$-4.27M	$-3.80M	$-3.38M	$1.36M	$-2.38M	$-3.14M	$-716.00K	$-2.41M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 16 years · 62 quarters

Anixa Biosciences Inc

Analytical Summary

16-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ANIX with peers